TP53 and cancer: In concordance with previous results suggesting that disruption in ATM-p53 pathway should enhance the sensitivity of cells to the disruption of the ATR pathway [23], VE-821 was shown to selectively induce cytotoxicity in cancer cells without affecting normal cells.